In a "targeted consultation" that could be the last opportunity to object before a major revision of EU guidance on manufacturing sterile drugs goes final, industry has again raised concerns about a proposal to require a filter testing strategy that it says could enable the very contamination it is intended to prevent.
Although the filter testing provision continued to draw complaints from industry groups asked to provide feedback, at least one of...